RAMM Pharma

RAMM Pharma Cash Flow per Share

The Operating Cash Flow per Share of RAMM Pharma (RAMM.CN) as of Oct 23, 2026 is -0.01 CAD. In the previous year, Operating Cash Flow per Share was -0.03 CAD — a change of -73.49% (higher).

Cash Flow per Share

-0.01CAD

YoY

-73.49%

Last updated:

Operating Cash Flow per Share of RAMM Pharma is 2025 -0.01 CAD. Operating Cash Flow per Share of RAMM Pharma was 2024 -0.03 CAD. It decreases by -73.49% higher compared to the previous year.

The RAMM Pharma Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
0.02 CAD
Jan 1, 2019
-0.02 CAD
Jan 1, 2020
-0.03 CAD
Jan 1, 2021
-0.03 CAD
Jan 1, 2022
-0.05 CAD
Jan 1, 2023
-0.04 CAD
Jan 1, 2024
-0.03 CAD
Jan 1, 2025
-0.01 CAD
The RAMM Pharma Cash Flow per Share history
YEARCash Flow per ShareYoY
-0.01CAD-73.49%
-0.03CAD-7.84%
-0.04CAD-24.78%
-0.05CAD+55.69%
-0.03CAD+6.17%
-0.03CAD+62.77%
-0.02CAD-206.84%
0.02CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RAMM Pharma Stock analysis

What does RAMM Pharma do? RAMM Pharma Corp generates revenue through cannabinoid pharmaceuticals and cannabis-based products, with brands like NettaLife, NettaPet, NettaPet Senior, NettaPet Puppies, and NettaVet targeting pet owners and veterinary markets. The company also sells cosmetics under the Cannabipiel line, including Cannabipiel Nite, Cannabipiel Body Lotion, and Cannabipiel Shampoo, catering to consumers seeking cannabinoid-infused skincare and personal care solutions. Subsidiaries such as Canapar Corp. and Medic Plast SA support production and commercialization across pharmaceutical specialties, household products, and food sectors. The firm’s product portfolio spans pharmaceuticals, pet care, cosmetics, and household items, with NettaPet and NettaVet focusing on animal health and Cannabipiel products targeting human skincare. Revenue streams include direct sales of branded items like Cannabipiel Tite and Cannabipiel Cleaning Emulsion to retail and specialty markets, while subsidiaries handle manufacturing and export operations for global distribution. Brands like Glediser SA and Yurelan SA contribute to the commercialization of diverse product categories under the company’s umbrella. RAMM Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RAMM Pharma stock

Operating Cash Flow per Share of RAMM Pharma is -0.01 CAD in 2025.

Operating Cash Flow per Share of RAMM Pharma changed from -0.03 CAD to -0.01 CAD, representing a -73.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share RAMM Pharma since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — RAMM Pharma

All Key Metrics — RAMM Pharma